Lynn Parente, MD
Obstetrics & Gynecology · San Antonio, TXNPI 1003891110
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,392 of the $2,826 with a category attached, or 84.6%. It is spread thinly across 28 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $869 and has fallen 72.9% since, to $235 in 2025.
Across 106 payments — averaging $26.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$675
- AbbVie$646
- Hologic Sales And Service, LLC$213
- Conmed Corporation$170
- Mayne Pharma Commercial LLC$165
- Mylan Pharmaceuticals Inc.$123
- plus $835 from 22 others
What the payments were for
- Travel & lodging$43415%
- Food & beverage$2,39285%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 4 | $675 |
| AbbVie | 31 | $646 |
| Hologic Sales And Service, LLC | 2 | $213 |
| Conmed Corporation | 2 | $170 |
| Mayne Pharma Commercial LLC | 8 | $165 |
| Mylan Pharmaceuticals Inc. | 7 | $123 |
| Daiichi Sankyo Inc. | 5 | $96 |
| Exeltis, USA Inc. | 4 | $73 |
| Avion Pharmaceuticals | 5 | $73 |
| Merck | 4 | $61 |
| Agile Therapeutics, Inc. | 4 | $60 |
| Lupin Inc. | 4 | $50 |
| Organon | 6 | $46 |
| Innovation Technologies Inc | 1 | $44 |
| Bayer | 2 | $44 |
| Scynexis, Inc. | 2 | $39 |
| Pfizer | 3 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Biogen | 1 | $28 |
| Coopersurgical, Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Duchesnay USA Incorporated | 1 | $18 |
| Covidien LP | 1 | $17 |
| Myovant Sciences Inc. | 1 | $15 |
| Millicent US Inc | 1 | $15 |
| Shield Therapeutics Inc | 1 | $15 |
| Minerva Surgical, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,826 in reported general payments places this provider in the 70th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 65 | $2,416 |
| Estradiol (Twice Weekly)Estradiol | 12 | $1,399 |
| ProgesteroneProgesterone, Micronized | 24 | $529 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $112 |
| Fluconazole | 18 | $61 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in San Antonio
- Henry Garza IiiSan Antonio$258K
- Valentin AlmendarezSan Antonio$215K
- Camilo GonimaSan Antonio$203K
- Paulina RamirezSan Antonio$51K
- Paula BilicaSan Antonio$41K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.